tiprankstipranks
Trending News
More News >
Advertisement

CGVV - ETF AI Analysis

Compare

Top Page

CGVV

Capital Group U.S. Large Value ETF (CGVV)

Rating:70Outperform
Price Target:
CGVV, the Capital Group U.S. Large Value ETF, has a solid overall rating driven by strong core holdings like APi Group, Vertex Pharmaceuticals, and GE Healthcare, which all show robust financial performance, positive earnings commentary, and clear strategic growth plans. Amazon and Applied Materials also add strength through strong business results, though their higher valuations and some technical weakness, along with more mixed names like Starbucks and Royal Caribbean that face leverage, cash flow, or profitability challenges, keep the fund from scoring even higher. The main risk factor is exposure to several companies with premium valuations and operational or regional headwinds, which could increase volatility if market conditions worsen.
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors, which can help reduce the impact if any one industry struggles.
Several Strong Top Holdings
Some of the largest positions, such as Applied Materials and Halliburton, have shown strong recent performance that supports the ETF’s overall returns.
Reasonable Expense Ratio
The fund’s fee is moderate for an actively managed value-focused ETF, allowing investors to keep more of their returns compared with higher-cost options.
Negative Factors
Heavy U.S. Concentration
With almost all assets in U.S. stocks, the fund offers little geographic diversification and is highly tied to the U.S. market’s fortunes.
Mixed Performance Among Top Holdings
Several major positions, including GE Healthcare, Berkshire Hathaway, and PayPal, have shown weaker recent performance, which can drag on the fund’s results.
Relatively Small Asset Base
The ETF manages a modest amount of assets, which can sometimes mean less trading liquidity and a shorter track record compared with larger, more established funds.

CGVV vs. SPDR S&P 500 ETF (SPY)

CGVV Summary

The Capital Group U.S. Large Value ETF (CGVV) is an actively managed fund that focuses on large U.S. companies that its managers believe are undervalued. It does not track a set index, but instead picks individual stocks across many sectors, including financials, technology, and industrials. Well-known holdings include Alphabet (Google’s parent company) and Amazon. Someone might invest in this ETF to seek long-term growth from solid, established businesses while staying diversified across many industries. A key risk is that these value stocks can still fall in price and will go up and down with the overall stock market.
How much will it cost me?The Capital Group U.S. Large Value ETF (CGVV) has an expense ratio of 0.33%, which means you’ll pay $3.30 per year for every $1,000 invested. This is slightly higher than average because it’s actively managed, meaning professional managers select stocks rather than following a passive index. Active management typically involves more research and trading, which increases costs.
What would affect this ETF?The Capital Group U.S. Large Value ETF (CGVV) could benefit from a stable U.S. economy and favorable conditions for undervalued large-cap stocks, especially in sectors like Financials and Industrials, which make up a significant portion of its holdings. However, rising interest rates or economic uncertainty could negatively impact its performance, particularly for companies in cyclical sectors like Consumer Cyclical and Energy. Regulatory changes or sector-specific challenges in top holdings like Berkshire Hathaway and Alphabet could also influence the ETF's future returns.

CGVV Top 10 Holdings

CGVV is leaning into a classic U.S. value story, but with a modern twist. Applied Materials is one of the main engines, rising on strong chip-equipment demand and giving the fund a tech-powered boost. On the flip side, Amazon has been losing steam lately, acting as a drag despite its long-term growth appeal. Industrial and energy names like APi Group and Halliburton are quietly pulling their weight, while steady contributors such as GE Healthcare and RTX add a defensive backbone. Overall, it’s a U.S.-only portfolio tilted toward industrials, financials, and selective tech rather than flashy growth names.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Amazon4.47%$4.53M$2.23T4.91%
71
Outperform
Starbucks3.50%$3.54M$112.96B1.06%
56
Neutral
APi Group3.15%$3.18M$17.38B61.10%
79
Outperform
GE Healthcare Technologies Inc3.11%$3.15M$32.25B-13.66%
78
Outperform
Berkshire Hathaway B3.09%$3.13M$1.06T-4.77%
66
Neutral
Applied Materials2.92%$2.95M$271.04B119.41%
77
Outperform
Halliburton2.81%$2.84M$28.22B34.38%
72
Outperform
Vertex Pharmaceuticals2.73%$2.76M$119.23B-7.02%
78
Outperform
Meta Platforms2.47%$2.49M$1.55T1.00%
76
Outperform
RTX2.46%$2.49M$274.52B57.34%
74
Outperform

CGVV Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
28.22
Negative
100DMA
27.37
Negative
200DMA
Market Momentum
MACD
-0.34
Positive
RSI
35.07
Neutral
STOCH
9.50
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CGVV, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 28.13, equal to the 50-day MA of 28.22, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.34 indicates Positive momentum. The RSI at 35.07 is Neutral, neither overbought nor oversold. The STOCH value of 9.50 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CGVV.

CGVV Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$101.17M0.33%
70
Outperform
$610.11M0.33%
71
Outperform
$511.85M0.56%
72
Outperform
$319.17M0.42%
72
Outperform
$306.20M0.71%
67
Neutral
$298.13M0.45%
70
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CGVV
Capital Group U.S. Large Value ETF
27.18
1.84
7.26%
TVAL
T. Rowe Price Value ETF
JDVL
John Hancock Disciplined Value Select ETF
FLV
American Century Focused Large Cap Value ETF
BASV
Brown Advisory Sustainable Value ETF
BLCV
BlackRock Large Cap Value ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement